Abbott Laboratories & Cosmos Health

Abbott Laboratories: Abbott Laboratories, a wholly owned subsidiary of Cosmos Health, will manufacture 2.86 million units of three pharmaceutical products for Pharmex S.A. over five years, leveraging its EU-GMP-licensed facility.

Cosmos Health: Cosmos Health, through its subsidiary Abbott Laboratories, entered into a five-year contract manufacturing agreement with Pharmex S.A., which is expected to strengthen its recurring revenue and maximize the utilization of its EU-licensed facilities.

Abbott Laboratories: Abbott Laboratories S.A., a wholly owned subsidiary of Cosmos Health, acquired the international patent application and will lead the efforts in pursuing patent protection and expanding nanotechnology-based product development platforms.

Cosmos Health: Cosmos Health Inc. has strengthened its proprietary IP portfolio and expanded its nanotechnology investment initiatives through the acquisition of a patent application, which is expected to drive long-term shareholder value and support the development of next-generation healthcare products.

Abbott Laboratories: Abbott Laboratories, a wholly owned subsidiary of Cosmos Health>>>, manufactures C-Scrub Wash 4% and will be responsible for the production of the veterinary formulation, leveraging its existing infrastructure.

Cosmos Health: Cosmos Health is expanding its product line into the animal health market with the launch of C-Scrub Wash 4% for veterinary use, which is expected to open new commercial opportunities and revenue streams for the company.

Abbott Laboratories: Abbott Laboratories is a manufacturing site owned by Cosmos Health, identified as a non-core real estate asset with a value of approximately $15 million that could be monetized.

Cosmos Health: Cosmos Health is exploring the monetization of approximately $20 million in non-core assets to strengthen its balance sheet, fund strategic initiatives, and potentially eliminate debt, which could significantly improve its financial position and market valuation.

Abbott Laboratories: Abbott Laboratories is a subsidiary of Cosmos Health involved in manufacturing pharmaceuticals and other health products within the European Union.

Cosmos Health: Cosmos Health Inc. announced record revenue for its subsidiary CosmoFarm, indicating strong performance and growth in its healthcare group. The company is investing in automation and facility expansion to support this growth.

Abbott Laboratories: Cana Laboratories is a subsidiary of Cosmos Health; the buyback does not directly affect its operations.

Cosmos Health: Cosmos Health is executing a $5 million share repurchase program, repurchasing 3.64 million shares for $700,000, signaling management's belief that shares are undervalued.